Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Biochemical and Molecular Characterization of Marstacimab and TFPI PathwaysRelease Date:Research Rare Disease Brazil, China, Germany, Italy, Japan, Korea, Netherlands, Saudi Arabia, Spain, Turkey, USA, United Kingdom Optimizing RSV diagnosis by improving RSV detection in patients admitted to ED/hospitalized due to respiratory symptomsRelease Date:Quality Improvement Vaccines Austria, Belgium, Bulgaria, Czech Republic, Finland, Greece, Ireland, Israel, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Sweden, Switzerland Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, China, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Title Grant Type Focus Area Country Application Due Date Transition of Care in VTERelease Date:Anticoagulation Education - NVAF or VTERelease Date:Review Process:Achievement of Treat-to-Target in Rheumatoid ArthritisRelease Date:Improving Care of Chronic Pain- Physician Groups and Health SystemsRelease Date:Facilitation of the Diagnosis of Rheumatoid ArthritisRelease Date:Pfizer and NCCN: Metastatic Breast CancerRelease Date:Pediatric Immunization Series CompletionRelease Date:Pfizer and National Psoriasis Foundation (NPF): Plugging the Treatment Gap in Psoriasis and Psoriatic ArthritisRelease Date:Pfizer and International Atherosclerosis Society (IAS): Lipid Management in High-Risk PatientsRelease Date:Pfizer and American Academy of Dermatology (AAD): Patient Access to CareRelease Date:Narrowing the Time Gap between Onset of Symptoms and Treatment for Rheumatoid ArthritisRelease Date:Pfizer and Global Bridges at Mayo Clinic: Treating Tobacco Dependence- Europe ProgramRelease Date:Implementation of MenB Vaccine Recommendations in Older Adolescents/Young AdultsRelease Date:Rheumatology FellowshipsRelease Date:Release Date:Review Process:IPI and Pfizer: Device Challenge- System for Dosing and Dispensing Multiparticulate Formulations of Pediatric DrugsRelease Date:Pfizer and American Pain Society: Improving Chronic Pain CareRelease Date:Accelerating Improvements in Medication OptimizationRelease Date:Review Process:Haemophilia Early Arthropathy Detection with UltraSound (HEAD-US) Protocol for Routine Joint Assessment of Haemophilia PatientsRelease Date:Improving Care of Patients with Atrial Fibrillation in Order to Reduce Stroke RiskRelease Date:IGLC_IHI_RFP Accelerating Improvements in Medication Optimization_Re-releaseRelease Date:Pfizer and Global Healthy Living Foundation: Rheumatoid Arthritis Shared Decision MakingRelease Date:Review Process:IBD Fellowship RFP 12212016Release Date:Rheumatology FellowshipRelease Date:Improving the Identification and Management of Adult Growth Hormone Deficiency (AGHD)Release Date:Improving Health Care Capacity in Immuno-OncologyRelease Date:Strategies to Support Increasing Exercise and Activity in Haemophilia PatientsRelease Date:Improving Pediatric ADHD Care – Innovative Implementation of a National GuidelineRelease Date:Reducing the Burden of Cardiovascular Disease in IndonesiaRelease Date:Shared Management of Psoriatic ArthritisRelease Date:Building Capacity for Tobacco Dependence Treatment in JapanRelease Date:Clinical Pathways in Breast CancerRelease Date:Dermatology Fellowship RFPRelease Date:Dermatology Early Career Investigator Quality Improvement ProjectsRelease Date:Review Process:Quality improvements in the Management of Atopic DermatitisRelease Date:Review Process:Programs Toward Improving the Quality of Depression TreatmentRelease Date:Improving Patient Care in Inflammatory Bowel Disease (IBD) through Shared Decision-MakingRelease Date:Review Process:Developing Clinical Research and Publication Skills - AfME and EURelease Date:Review Process:Developing Clinical Research and Publication Skills – UKRelease Date:Review Process:Inflammatory Bowel Disease FellowshipsRelease Date:Improving Health Outcomes in Atopic Dermatitis (AD) through Shared Decision-MakingRelease Date:Review Process:Patient Decision Aids for Inflammatory ConditionsRelease Date:Review Process:Improving Assessment and Treatment of Acute Vaso-occlusive CrisisRelease Date:Rheumatology FellowshipRelease Date:Review Process:Developing Clinical Research and Publication Skills – UK (Re-release)Release Date:Review Process:Developing Clinical Research and Publication Skills - AfME and EU (Re-release)Release Date:Review Process:Dermatology FellowshipRelease Date:Review Process: